Literature DB >> 19621317

[Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].

L Rami1, B Bosch, C Valls-Pedret, C Caprile, R Sánchez-Valle Díaz, J L Molinuevo.   

Abstract

AIMS: To establish the discriminatory validity of the mini-mental test (MMSE) and the memory alteration test (M@T) for the diagnosis of amnestic mild cognitive impairment (aMCI) and probable Alzheimer's disease (AD), and also to study the association between the results obtained in screening tests, a neuropsychological battery and a functional questionnaire in healthy persons and in patients with aMCI and AD. SUBJECTS AND METHODS: We evaluated 27 normal controls, 27 patients with aMCI and 35 patients with AD using the MMSE and a memory screening test, the M@T, a neuropsychological battery and a questionnaire on functional activities of daily living. Pearson correlation coefficients were used to evaluate the relations between the scores on the M@T and the MMSE and the neuropsychological tests. The area below the curve, the sensitivity and the specificity were calculated for the screening tests.
RESULTS: In patients with aMCI, the scores on the M@T and the MMSE were strongly associated with the performance in the episodic memory tests in frontal tests and with the scores on the functional questionnaire, but not with tests that evaluated praxias and perceptive functions. In patients with AD, the scores on the M@T and the MMSE were associated with results in semantic memory, language, executive functions and praxias, but not with perceptive tests and functional questionnaires.
CONCLUSIONS: In patients with aMCI and AD, the association between MMSE and M@T only correlate with some cognitive functions, without there being any association with other cognitive functions. Therefore, screening tests cannot be used as the only instrument for evaluating the cognitive status in patients with suspected dementia.

Entities:  

Mesh:

Year:  2009        PMID: 19621317

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  6 in total

1.  Effectiveness and costs of phototest in dementia and cognitive impairment screening.

Authors:  Cristobal Carnero-Pardo; Beatriz Espejo-Martinez; Samuel Lopez-Alcalde; Maria Espinosa-Garcia; Carmen Saez-Zea; Rosa Vilchez-Carrillo; Elisa Hernandez-Torres; Jose L Navarro-Espigares
Journal:  BMC Neurol       Date:  2011-07-29       Impact factor: 2.474

2.  Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old.

Authors:  Montserrat Alegret; Ana Espinosa; Sergi Valero; Georgina Vinyes-Junqué; Agustín Ruiz; Isabel Hernández; Maitee Rosende-Roca; Ana Mauleón; James T Becker; Lluís Tárraga; Mercè Boada
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

3.  Memory Alteration Test to Detect Amnestic Mild Cognitive Impairment and Early Alzheimer's Dementia in Population with Low Educational Level.

Authors:  Nilton Custodio; David Lira; Eder Herrera-Perez; Rosa Montesinos; Sheila Castro-Suarez; José Cuenca-Alfaro; Lucía Valeriano-Lorenzo
Journal:  Front Aging Neurosci       Date:  2017-08-22       Impact factor: 5.750

4.  Legal medical consideration of Alzheimer's disease patients' dysgraphia and cognitive dysfunction: a 6 month follow up.

Authors:  Emanuela Onofri; Marco Mercuri; Trevor Archer; Max Rapp-Ricciardi; Serafino Ricci
Journal:  Clin Interv Aging       Date:  2016-03-07       Impact factor: 4.458

5.  Criterion validity of a Wechsler-III Scale Short Form in a sample of brazilian elderly.

Authors:  Eliane Ferreira Carvalho Banhato; Isabel Cristina Gonçalves Leite; Danielle Viveiros Guedes; Alfredo Chaoubah
Journal:  Dement Neuropsychol       Date:  2010 Jul-Sep

6.  [Effectiveness of the Mini-Mental State for detection of cognitive impairment in primary care].

Authors:  Cristóbal Carnero Pardo; Isabel Cruz Orduña; Beatriz Espejo Martínez; Salvador Cárdenas Viedma; Pedro Torrero García; Javier Olazarán Rodríguez
Journal:  Aten Primaria       Date:  2013-07-17       Impact factor: 1.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.